grant

The evaluation of gamma-glutamylcyclotransferase as a novel target for cancer therapy and diagnosis [ 2009 - 2012 ]

Also known as: gamma-glutamylcyclotransferase as a novel target for cancer therapy

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/525458]

Researchers: Prof Philip Board (Principal investigator) ,  The Australian National University (Managed by)

Brief description Gamma glutamylcyclotransferase (GGCT) plays a pivotal role in regulating the synthesis of glutathione, a compound that is essential for life and regulates many intracellular processes. Several recent studies have shown that GGCT is highly expressed in cancer cells . This study will determine if GGCT is a target for cancer chemotherapy or if it can be used for cancer diagnosis. This study may also provide a new treatment for patients with glutathione synthetase deficiency.

Funding Amount $AUD 433,900.62

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857